Heterocyclic arylsulfonamidobenzylic compounds are provided which are useful in treating lipid disorders, metabolic disorders and cell-proliferative diseases.
提供了杂环芳基磺酰胺基苯基化合物,可用于治疗脂质紊乱、代谢紊乱和细胞增殖性疾病。
Discovery of a new binding mode for a series of liver X receptor agonists
作者:David J. Kopecky、Xian Yun Jiao、Ben Fisher、Sharon McKendry、Marc Labelle、Derek E. Piper、Peter Coward、Andrew K. Shiau、Patrick Escaron、Jean Danao、Anne Chai、Juan Jaen、Frank Kayser
DOI:10.1016/j.bmcl.2012.02.028
日期:2012.4
Structural modification of a series of dual LXR alpha/beta agonists led to the identification of a new class of LXR beta partial agonists. An X-ray co-crystal structure shows that a representative member of this series, pyrrole 5, binds to LXR beta with a reversed orientation compared to 1. (C) 2012 Elsevier Ltd. All rights reserved.